======= NFKBIZ =======
== Gene Information ==
* **Official Symbol**: NFKBIZ
* **Official Name**: NFKB inhibitor zeta
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64332|64332]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BYH8|Q9BYH8]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NFKBIZ&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NFKBIZ|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608004|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in regulation of NF-kappa-B transcription factor complexes. Inhibits NF-kappa-B activity without affecting its nuclear translocation upon stimulation. Inhibits DNA-binding of RELA and NFKB1/p50, and of the NF-kappa-B p65-p50 heterodimer and the NF-kappa-B p50-p50 homodimer. Seems also to activate NF- kappa-B-mediated transcription. In vitro, upon association with NFKB1/p50 has transcriptional activation activity and, together with NFKB1/p50 and RELA, is recruited to LCN2 promoters. Promotes transcription of LCN2 and DEFB4. Is recruited to IL-6 promoters and activates IL-6 but decreases TNF-alpha production in response to LPS. Seems to be involved in the induction of inflammatory genes activated through TLR/IL-1 receptor signaling. May promote apoptosis (By similarity). {ECO:0000250, ECO:0000269|PubMed:16513645, ECO:0000269|PubMed:16622025}.
|Ank 2|
|positive regulation of T-helper 17 cell differentiation|
|positive regulation of T-helper 17 type immune response|
|regulation of T-helper 17 cell differentiation|
|regulation of T-helper 17 type immune response|
|positive regulation of T-helper cell differentiation|
|positive regulation of CD4-positive, alpha-beta T cell differentiation|
|positive regulation of CD4-positive, alpha-beta T cell activation|
|regulation of T-helper cell differentiation|
|positive regulation of alpha-beta T cell differentiation|
|regulation of CD4-positive, alpha-beta T cell differentiation|
|positive regulation of alpha-beta T cell activation|
|regulation of CD4-positive, alpha-beta T cell activation|
|regulation of alpha-beta T cell differentiation|
|cytoplasmic ribonucleoprotein granule|
|positive regulation of T cell differentiation|
|regulation of alpha-beta T cell activation|
|positive regulation of lymphocyte differentiation|
|positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|
|positive regulation of adaptive immune response|
|regulation of T cell differentiation|
|positive regulation of inflammatory response|
|regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|
|positive regulation of leukocyte differentiation|
|regulation of adaptive immune response|
|regulation of lymphocyte differentiation|
|T cell receptor signaling pathway|
|positive regulation of hemopoiesis|
|positive regulation of T cell activation|
|positive regulation of leukocyte cell-cell adhesion|
|positive regulation of immune effector process|
|positive regulation of cell-cell adhesion|
|regulation of leukocyte differentiation|
|antigen receptor-mediated signaling pathway|
|regulation of leukocyte cell-cell adhesion|
|regulation of T cell activation|
|regulation of inflammatory response|
|positive regulation of lymphocyte activation|
|regulation of cell-cell adhesion|
|nuclear speck|
|positive regulation of cell adhesion|
|positive regulation of leukocyte activation|
|positive regulation of cell activation|
|immune response-activating cell surface receptor signaling pathway|
|regulation of hemopoiesis|
|regulation of immune effector process|
|positive regulation of defense response|
|immune response-regulating cell surface receptor signaling pathway|
|inflammatory response|
|regulation of lymphocyte activation|
|immune response-activating signal transduction|
|immune response-regulating signaling pathway|
|regulation of leukocyte activation|
|positive regulation of response to external stimulus|
|activation of immune response|
|regulation of cell activation|
|regulation of cell adhesion|
|regulation of defense response|
|positive regulation of immune response|
|positive regulation of cell differentiation|
|regulation of response to external stimulus|
|positive regulation of immune system process|
|regulation of immune response|
|defense response|
|positive regulation of developmental process|
|regulation of response to stress|
|regulation of immune system process|
|positive regulation of multicellular organismal process|
|regulation of cell differentiation|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp292|Menadione 5μM R06 exp292]]|-2.22|
|[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.86|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6391
* **Expression level (log2 read counts)**: 2.31
{{:chemogenomics:nalm6 dist.png?nolink |}}